|
MERTK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.35229999995457E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.898340E-02 |
| Normal-vs-Stage2 |
4.660200E-01 |
| Normal-vs-Stage3 |
3.77210040980458E-10 |
| Normal-vs-Stage4 |
2.02309999999262E-05 |
| Stage1-vs-Stage2 |
7.220400E-01 |
| Stage1-vs-Stage3 |
1.60068999999208E-05 |
| Stage1-vs-Stage4 |
3.119400E-03 |
| Stage2-vs-Stage3 |
1.519980E-02 |
| Stage2-vs-Stage4 |
2.307800E-02 |
| Stage3-vs-Stage4 |
9.413600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.7294899999909E-05 |
| Normal-vs-AfricanAmerican |
5.166600E-04 |
| Normal-vs-Asian |
9.021200E-01 |
| Caucasian-vs-AfricanAmerican |
4.034200E-01 |
| Caucasian-vs-Asian |
2.820400E-01 |
| AfricanAmerican-vs-Asian |
1.210210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.85900000000605E-05 |
| Normal-vs-Female |
2.577600E-04 |
| Male-vs-Female |
9.114600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.310230E-01 |
| Normal-vs-Age(41-60Yrs) |
4.960200E-04 |
| Normal-vs-Age(61-80Yrs) |
7.71780000000666E-05 |
| Normal-vs-Age(81-100Yrs) |
1.046370E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.807200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.628400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.944600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.242400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.550800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.080800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.960100E-02 |
| Normal-vs-Grade 2 |
1.571860E-02 |
| Normal-vs-Grade 3 |
2.16779999995254E-06 |
| Normal-vs-Grade 4 |
1.91998999999887E-05 |
| Grade 1-vs-Grade 2 |
6.001800E-01 |
| Grade 1-vs-Grade 3 |
6.674000E-01 |
| Grade 1-vs-Grade 4 |
8.766100E-02 |
| Grade 2-vs-Grade 3 |
3.584300E-02 |
| Grade 2-vs-Grade 4 |
1.475980E-03 |
| Grade 3-vs-Grade 4 |
8.943500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.136460E-02 |
| Normal-vs-ccB subtype |
1.641490E-04 |
| ccA subtype-vs-ccB subtype |
8.443600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.723700E-03 |
| Normal-vs-N1 |
4.642200E-01 |
| N0-vs-N1 |
8.657600E-01 |
|
|
